The relationship between PSP, CBD, and NRF2 has been identified in a study combining genome-wide maps of NRF2/sMAF occupancy with disease-risk SNPs identified in GWAS [101]. Here, NFE2L2 is linked to supranuclear palsy, progressive, 1.